Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review

Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range...

Full description

Saved in:
Bibliographic Details
Published inHealth policy and planning Vol. 38; no. 3; pp. 363 - 376
Main Authors Guillaume, Dominique, Meyer, Diane, Waheed, Dur-e-Nayab, Schlieff, Meike, Muralidharan, Kirthini, Chou, Victoria B, Limaye, Rupali
Format Journal Article
LanguageEnglish
Published UK Oxford University Press 16.03.2023
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.
AbstractList Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.
Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country's specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country's specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.
Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.
Author Chou, Victoria B
Meyer, Diane
Schlieff, Meike
Limaye, Rupali
Waheed, Dur-e-Nayab
Muralidharan, Kirthini
Guillaume, Dominique
Author_xml – sequence: 1
  givenname: Dominique
  orcidid: 0000-0003-3963-4986
  surname: Guillaume
  fullname: Guillaume, Dominique
  email: dguilla2@jhu.edu
– sequence: 2
  givenname: Diane
  surname: Meyer
  fullname: Meyer, Diane
– sequence: 3
  givenname: Dur-e-Nayab
  surname: Waheed
  fullname: Waheed, Dur-e-Nayab
– sequence: 4
  givenname: Meike
  surname: Schlieff
  fullname: Schlieff, Meike
– sequence: 5
  givenname: Kirthini
  surname: Muralidharan
  fullname: Muralidharan, Kirthini
– sequence: 6
  givenname: Victoria B
  surname: Chou
  fullname: Chou, Victoria B
– sequence: 7
  givenname: Rupali
  orcidid: 0000-0002-3883-9720
  surname: Limaye
  fullname: Limaye, Rupali
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36315461$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1LHTEUxUOx1M9tlyXQTbsYzdfMvOlOpFZB6MZ9yNzc1NiZZJpktM-_vqPvCUUQV7mQ3zn3cs4-2QkxICEfOTvmrJMnN2imOJzAgwHWiXdkj6uGVULIdue_eZfs53zLGFdK1R_Irmwkr1XD98jfcwMlpkx9cMOMAXz4RcsN0in5mHzxD6b4GGh09M7A8ouZ9mu67PSwHs1vfJLSId5X1ARLR2_tgJUPEEekEOdQksf8jRqaIU6P7gnvPN4fkvfODBmPtu8BuT7_fn12UV39_HF5dnpVgZKsVL2wnatR9LZRCkWLnbO8da4RPVsph8bWTEiwzcqAYHXrpOwUAkrT9QI6eUC-bGynFP_MmIsefQYcBhMwzlmLVrJGyZo1C_r5BXob5xSW47RkNRf1qmVqoT5tqbkf0eolp9GktX6OdAHUBoAUc07oNPjyFGJJxg-aM_3YnN40p7fNLbLjF7Jn51cFXzeCOE9vsf8ASpSuZA
CitedBy_id crossref_primary_10_2147_AHMT_S394119
crossref_primary_10_1186_s41182_023_00564_2
crossref_primary_10_1093_heapol_czae059
crossref_primary_10_1080_21645515_2024_2411823
crossref_primary_10_7759_cureus_76223
crossref_primary_10_3390_vaccines12020201
crossref_primary_10_1093_infdis_jiaf038
crossref_primary_10_3390_vaccines12020184
crossref_primary_10_1002_jmv_29900
crossref_primary_10_3390_vaccines12030337
crossref_primary_10_1111_inr_13022
crossref_primary_10_3390_vaccines12070767
crossref_primary_10_1080_16549716_2023_2281065
crossref_primary_10_1371_journal_pone_0294480
crossref_primary_10_1016_S2214_109X_23_00457_6
Cites_doi 10.3389/fpubh.2022.860809
10.1093/infdis/jiw601
10.1016/j.coi.2021.03.006
10.1371/journal.pntd.0002127
10.1200/GO.20.00504
10.1586/14760584.2016.1166961
10.1186/1471-2288-8-45
10.1098/rstb.2011.0046
10.15585/mmwr.mm6745a2
10.1097/XEB.0000000000000050
10.1016/j.vaccine.2018.07.063
10.1016/j.vaccine.2018.06.001
10.1093/heapol/czr049
10.1016/S0264-410X(03)00533-4
10.1093/heapol/czs039
10.1186/s12936-021-03966-x
10.1016/j.vaccine.2012.04.027
10.15171/ijhpm.2017.37
10.1093/heapol/czs040
10.1016/j.vaccine.2020.03.005
10.1016/j.vaccine.2021.06.074
10.1377/hlthaff.2015.1418
10.1016/j.vaccine.2021.02.055
10.1093/heapol/czs035
10.1093/infdis/jiab284
10.1186/s12874-018-0611-x
10.1186/s12992-021-00745-w
10.2174/1875035400902010113
10.1186/1475-2875-9-182
10.1093/heapol/czs036
10.1093/heapol/czs037
10.1056/NEJMp2029466
10.1186/s12936-016-1197-6
10.3329/jhpn.v31i2.16385
10.1016/j.vaccine.2004.11.044
10.1016/S0140-6736(20)30068-4
10.1016/S0140-6736(20)32657-X
10.3389/fpubh.2021.598625
10.1590/S0102-311X2010000500012
10.1080/14760584.2019.1574224
10.1177/1049732305276687
10.1186/s13012-021-01101-7
10.1093/heapol/czz027
10.1016/j.vaccine.2013.05.032
10.1177/2059799118789021
10.1080/21645515.2021.1893062
10.1186/s12889-021-12196-4
10.1016/j.socscimed.2007.05.054
10.1016/j.ypmed.2020.106335
10.1016/j.vaccine.2019.05.046
10.1093/heapol/czw038
10.1016/j.vaccine.2014.10.090
10.3389/fpubh.2022.799984
10.1016/j.vaccine.2018.11.062
10.1016/j.vaccine.2014.12.073
10.1186/s12889-015-1638-0
10.1590/S1020-49892009001100003
10.7326/M18-0850
10.1016/j.vaccine.2010.02.043
ContentType Journal Article
Copyright Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2022
Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Copyright_xml – notice: Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2022
– notice: Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7T2
7TQ
8BJ
C1K
DHY
DON
FQK
JBE
K9.
7X8
DOI 10.1093/heapol/czac092
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
Health and Safety Science Abstracts (Full archive)
PAIS Index
International Bibliography of the Social Sciences (IBSS)
Environmental Sciences and Pollution Management
PAIS International
PAIS International (Ovid)
International Bibliography of the Social Sciences
International Bibliography of the Social Sciences
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
International Bibliography of the Social Sciences (IBSS)
Applied Social Sciences Index and Abstracts (ASSIA)
PAIS International
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1460-2237
EndPage 376
ExternalDocumentID 36315461
10_1093_heapol_czac092
10.1093/heapol/czac092
Genre Journal Article
Scoping Review
GroupedDBID ---
-E4
.2P
.I3
.ZR
0R~
18M
1TH
29I
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
70D
A8Z
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUQX
AAVAP
AAWDT
AAWTL
ABBHK
ABEUO
ABIVO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABPTD
ABQLI
ABQTQ
ABSAR
ABSMQ
ABWST
ABXSQ
ABXVV
ABYLZ
ABZBJ
ACFRR
ACGFO
ACGFS
ACHQT
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACVHY
ADACV
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADJQC
ADOCK
ADPDF
ADQBN
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEAAH
AEGPL
AEJOX
AEJYH
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFRAH
AFSHK
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGQXC
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AILCM
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATTQO
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
BWUDY
BZKNY
C1A
C45
CAG
CDBKE
CNZYI
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EGZRM
EIHJH
EJD
EMOBN
ESTFP
F5P
F9B
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
FTKQU
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JENOY
JKPJF
JPL
JPM
JSODD
JST
JVCUD
KAQDR
KBUDW
KC5
KOP
KQ8
KSI
KSN
M-Z
M49
MBLQV
MS~
N9A
NGC
NOMLY
NOYVH
NPJNY
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
ODMLO
OJQWA
OK1
OPAEJ
OVD
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RPM
RUSNO
RW1
RXO
RZF
RZO
SA0
SV3
TJX
TMA
TOX
TR2
W8F
WH7
WOQ
X7H
YAYTL
YHZ
YKOAZ
YXANX
ZKX
~91
~OX
~OY
~P0
AAYXX
ABEJV
ABGNP
ABPQP
ADMHG
AGQZG
AHGBF
ALXQX
AMHCJ
AMNDL
CITATION
JXSIZ
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7T2
7TQ
8BJ
C1K
DHY
DON
FQK
JBE
K9.
7X8
ID FETCH-LOGICAL-c430t-b2d9f5e2bd644e27e9fd17ff62b084fead5023cd68ac2057f3394ece3a9b2c93
IEDL.DBID TOX
ISSN 1460-2237
0268-1080
IngestDate Fri Jul 11 00:42:05 EDT 2025
Thu Jul 03 23:40:05 EDT 2025
Mon Jul 21 06:05:12 EDT 2025
Tue Jul 01 01:15:56 EDT 2025
Thu Apr 24 23:00:51 EDT 2025
Wed Aug 28 03:18:19 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Decision-making
vaccine introduction
low- and middle-income countries
policy evaluation
Language English
License This work is written by (a) US Government employee(s) and is in the public domain in the US.
Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c430t-b2d9f5e2bd644e27e9fd17ff62b084fead5023cd68ac2057f3394ece3a9b2c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-3963-4986
0000-0002-3883-9720
OpenAccessLink https://academic.oup.com/heapol/article-pdf/38/3/363/49543108/czac092.pdf
PMID 36315461
PQID 3051258704
PQPubID 34190
PageCount 14
ParticipantIDs proquest_miscellaneous_2730643506
proquest_journals_3051258704
pubmed_primary_36315461
crossref_citationtrail_10_1093_heapol_czac092
crossref_primary_10_1093_heapol_czac092
oup_primary_10_1093_heapol_czac092
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-03-16
PublicationDateYYYYMMDD 2023-03-16
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-16
  day: 16
PublicationDecade 2020
PublicationPlace UK
PublicationPlace_xml – name: UK
– name: England
– name: Oxford
PublicationTitle Health policy and planning
PublicationTitleAlternate Health Policy Plan
PublicationYear 2023
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References Li (2023071115181474900_R35) 2021; 397
Brooks (2023071115181474900_R8) 2012; 27
Tricco (2023071115181474900_R57) 2018; 169
Guignard (2023071115181474900_R24) 2019; 18
Ngcobo (2023071115181474900_R45) 2021; 71
Blau (2023071115181474900_R6) 2015; 33
Brisson (2023071115181474900_R7) 2020; 395
DeRoeck (2023071115181474900_R19) 2003; 22
Milstien (2023071115181474900_R39) 2010; 9
Burchett (2023071115181474900_R9) 2012; 27
DeRoeck (2023071115181474900_R18) 2005; 23
Wallace (2023071115181474900_R64) 2017; 6
Gordon (2023071115181474900_R23) 2012; 27
Kollamparambil (2023071115181474900_R34) 2021; 21
Amponsah-Dacosta (2023071115181474900_R1) 2022; 10
Thomas (2023071115181474900_R56) 2008; 8
VanderEnde (2023071115181474900_R62) 2019; 67
Burns (2023071115181474900_R11) 2009; 26
NCI (2023071115181474900_R43) 2021
Ngcobo (2023071115181474900_R44) 2012; 30
Ikilezi (2023071115181474900_R30) 2020; 38
Shinkafi-Bagudu (2023071115181474900_R54) 2020; 6
Gerberding (2023071115181474900_R22) 2021; 384
Hasan (2023071115181474900_R27) 2018; 36
Shen (2023071115181474900_R53) 2016; 35
GAVI TVA (2023071115181474900_R21) 2020
Makinen (2023071115181474900_R37) 2012; 27
Steffen (2023071115181474900_R55) 2021; 39
Peters (2023071115181474900_R49) 2015; 13
Hajjeh (2023071115181474900_R26) 2011; 366
Khosa (2023071115181474900_R33) 2022; 10
Milondzo (2023071115181474900_R38) 2021; 9
Douglas (2023071115181474900_R20) 2013; 7
Bell (2023071115181474900_R5) 2019; 34
Howard (2023071115181474900_R28) 2018; 36
Tsui (2023071115181474900_R58) 2009; 2
Munira (2023071115181474900_R41) 2007; 65
Wiysonge (2023071115181474900_R68) 2021; 18
Otieno (2023071115181474900_R48) 2021; 16
WHO (2023071115181474900_R66) 2022
Lindstrand (2023071115181474900_R36) 2021; 224
Van Der Putten (2023071115181474900_R63) 2015; 15
Decouttere (2023071115181474900_R14) 2021; 17
Aromataris (2023071115181474900_R2) 2017
Hadisoemarto (2023071115181474900_R25) 2016; 31
Hsieh (2023071115181474900_R29) 2005; 15
Piñeros (2023071115181474900_R50) 2010; 26
Nha HONG (2023071115181474900_R46) 2018
Uddin (2023071115181474900_R60) 2013; 31
Wilson (2023071115181474900_R67) 2021; 39
Ba-Nguz (2023071115181474900_R3) 2017; 216
Unwin (2023071115181474900_R61) 2021; 20
Wonodi (2023071115181474900_R69) 2012; 27
Nzabonimpa (2023071115181474900_R47) 2018; 11
Tsu (2023071115181474900_R59) 2021; 144
DeRoeck (2023071115181474900_R17) 2004; 22
WHO (2023071115181474900_R65) 2021
Ba-Nguz (2023071115181474900_R4) 2019; 37
Munn (2023071115181474900_R42) 2018; 18
Rattanavipapong (2023071115181474900_R51) 2020; 9
de Oliveira (2023071115181474900_R16) 2016; 15
Romore (2023071115181474900_R52) 2016; 15
Clemens (2023071115181474900_R12) 2004; 22
Jauregui (2023071115181474900_R31) 2015; 33
de Oliveira (2023071115181474900_R15) 2013; 31
Muangchana (2023071115181474900_R40) 2010; 28
KFF (2023071115181474900_R32) 2022
Dawa (2023071115181474900_R13) 2019; 37
Burchett (2023071115181474900_R10) 2012; 27
References_xml – volume: 10
  start-page: 1
  year: 2022
  ident: 2023071115181474900_R33
  article-title: Vaccine hesitancy drives low human papillomavirus vaccination coverage in girls attending public schools in South Africa
  publication-title: Frontiers in Public Health
  doi: 10.3389/fpubh.2022.860809
– volume: 216
  start-page: S109
  year: 2017
  ident: 2023071115181474900_R3
  article-title: The role of National Immunization Technical Advisory Groups (NITAGs) in the introduction of inactivated polio vaccine: experience of the Indonesia and Uganda NITAGs
  publication-title: The Journal of Infectious Diseases
  doi: 10.1093/infdis/jiw601
– volume: 71
  start-page: 21
  year: 2021
  ident: 2023071115181474900_R45
  article-title: Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination
  publication-title: Current Opinion in Immunology
  doi: 10.1016/j.coi.2021.03.006
– volume: 7
  year: 2013
  ident: 2023071115181474900_R20
  article-title: Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders
  publication-title: PLoS Neglected Tropical Diseases
  doi: 10.1371/journal.pntd.0002127
– volume: 6
  start-page: 1746
  year: 2020
  ident: 2023071115181474900_R54
  article-title: Global partnerships for HPV vaccine must look beyond national income
  publication-title: JCO Global Oncology
  doi: 10.1200/GO.20.00504
– volume: 15
  start-page: 1295
  year: 2016
  ident: 2023071115181474900_R16
  article-title: Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned
  publication-title: Expert Review of Vaccines
  doi: 10.1586/14760584.2016.1166961
– year: 2017
  ident: 2023071115181474900_R2
  article-title: 8.2 Concepts and considerations for mixed methods systematic reviews
– volume: 8
  year: 2008
  ident: 2023071115181474900_R56
  article-title: Methods for the thematic synthesis of qualitative research in systematic reviews
  publication-title: BMC Medical Research Methodology
  doi: 10.1186/1471-2288-8-45
– volume: 366
  start-page: 2827
  year: 2011
  ident: 2023071115181474900_R26
  article-title: Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience
  publication-title: Philosophical Transactions of the Royal Society B: Biological Sciences
  doi: 10.1098/rstb.2011.0046
– volume: 67
  start-page: 1261
  year: 2019
  ident: 2023071115181474900_R62
  article-title: Global routine vaccination coverage — 2017
  publication-title: MMWR Morbidity and Mortality Weekly Report
  doi: 10.15585/mmwr.mm6745a2
– volume: 13
  start-page: 141
  year: 2015
  ident: 2023071115181474900_R49
  article-title: Guidance for conducting systematic scoping reviews
  publication-title: International Journal of Evidence Based Healthcare
  doi: 10.1097/XEB.0000000000000050
– volume: 36
  start-page: 5536
  year: 2018
  ident: 2023071115181474900_R28
  article-title: The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: a comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.07.063
– volume: 36
  start-page: 4939
  year: 2018
  ident: 2023071115181474900_R27
  article-title: Using pneumococcal and rotavirus surveillance in vaccine decision-making: a series of case studies in Bangladesh, Armenia and the Gambia
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.06.001
– volume: 27
  start-page: ii62
  year: 2012
  ident: 2023071115181474900_R10
  article-title: National decision-making on adopting new vaccines: a systematic review
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czr049
– volume: 22
  start-page: 121
  year: 2003
  ident: 2023071115181474900_R19
  article-title: Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(03)00533-4
– volume: 27
  start-page: 50
  year: 2012
  ident: 2023071115181474900_R8
  article-title: Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions Downloaded from KEY MESSAGES
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czs039
– volume: 20
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R61
  article-title: Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
  publication-title: Malaria Journal
  doi: 10.1186/s12936-021-03966-x
– volume: 30
  start-page: C9
  year: 2012
  ident: 2023071115181474900_R44
  article-title: The decision making process on new vaccines introduction in South Africa
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.04.027
– volume: 6
  start-page: 707
  year: 2017
  ident: 2023071115181474900_R64
  article-title: How are new vaccines prioritized in low-income countries? A case study of human papilloma virus vaccine and pneumococcal conjugate vaccine in Uganda
  publication-title: International Journal of Health Policy and Management
  doi: 10.15171/ijhpm.2017.37
– volume: 27
  start-page: ii17
  year: 2012
  ident: 2023071115181474900_R23
  article-title: Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czs040
– volume: 38
  start-page: 3447
  year: 2020
  ident: 2023071115181474900_R30
  article-title: Determinants of geographical inequalities for DTP3 vaccine coverage in sub-Saharan Africa
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.03.005
– volume: 39
  start-page: 5277
  year: 2021
  ident: 2023071115181474900_R67
  article-title: HPV vaccine acceptance in West Africa: a systematic literature review
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2021.06.074
– volume: 35
  start-page: 272
  year: 2016
  ident: 2023071115181474900_R53
  article-title: Country ownership and gavi transition: comprehensive approaches to supporting new vaccine introduction
  publication-title: Health Affairs
  doi: 10.1377/hlthaff.2015.1418
– volume: 39
  start-page: 2146
  year: 2021
  ident: 2023071115181474900_R55
  article-title: Evidence-informed vaccination decision-making in countries: progress, challenges and opportunities
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2021.02.055
– year: 2022
  ident: 2023071115181474900_R66
  article-title: WHO Evidence Considerations for Vaccine Policy Development (ECVP)
– volume: 22
  start-page: 322
  year: 2004
  ident: 2023071115181474900_R17
  article-title: The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys
  publication-title: Journal of Health, Population, and Nutrition
– volume: 27
  start-page: ii5
  year: 2012
  ident: 2023071115181474900_R9
  article-title: New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czs035
– volume: 224
  start-page: S452
  year: 2021
  ident: 2023071115181474900_R36
  article-title: The world of immunization: achievements, challenges, and strategic vision for the next decade
  publication-title: The Journal of Infectious Diseases
  doi: 10.1093/infdis/jiab284
– volume: 18
  year: 2018
  ident: 2023071115181474900_R42
  article-title: Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
  publication-title: BMC Medical Research Methodology
  doi: 10.1186/s12874-018-0611-x
– volume: 17
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R14
  article-title: Advancing sustainable development goals through immunization: a literature review
  publication-title: Globalization and Health
  doi: 10.1186/s12992-021-00745-w
– volume: 2
  start-page: 113
  year: 2009
  ident: 2023071115181474900_R58
  article-title: Policy development for human papillomavirus vaccine introduction in low-resource settings
  publication-title: The Open Vaccine Journal
  doi: 10.2174/1875035400902010113
– volume: 9
  year: 2010
  ident: 2023071115181474900_R39
  article-title: WHO policy development processes for a new vaccine: case study of malaria vaccines
  publication-title: Malaria Journal
  doi: 10.1186/1475-2875-9-182
– volume: 27
  start-page: ii39
  year: 2012
  ident: 2023071115181474900_R37
  article-title: New vaccine adoption in lower-middle-income countries
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czs036
– volume: 27
  start-page: ii27
  year: 2012
  ident: 2023071115181474900_R69
  article-title: Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czs037
– volume: 384
  start-page: 393
  year: 2021
  ident: 2023071115181474900_R22
  article-title: Vaccine innovations — past and future
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMp2029466
– volume: 15
  year: 2016
  ident: 2023071115181474900_R52
  article-title: Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
  publication-title: Malaria Journal
  doi: 10.1186/s12936-016-1197-6
– volume: 31
  year: 2013
  ident: 2023071115181474900_R60
  article-title: Introduction of new vaccines: decision-making process in Bangladesh
  publication-title: Journal of Health, Population, and Nutrition
  doi: 10.3329/jhpn.v31i2.16385
– year: 2021
  ident: 2023071115181474900_R43
  article-title: Human Papillomavirus (HPV) Vaccines - National Cancer Institute
– year: 2018
  ident: 2023071115181474900_R46
  article-title: MIXED METHODS APPRAISAL TOOL (MMAT) VERSION 2018 User guide
– volume: 23
  start-page: 2762
  year: 2005
  ident: 2023071115181474900_R18
  article-title: Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2004.11.044
– volume: 395
  year: 2020
  ident: 2023071115181474900_R7
  article-title: Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(20)30068-4
– volume: 397
  start-page: 398
  year: 2021
  ident: 2023071115181474900_R35
  article-title: Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(20)32657-X
– volume: 9
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R38
  article-title: Misinformation drives low human papillomavirus vaccination coverage in South African Girls Attending Private Schools
  publication-title: Frontiers in Public Health
  doi: 10.3389/fpubh.2021.598625
– volume: 26
  start-page: 900
  year: 2010
  ident: 2023071115181474900_R50
  article-title: HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors
  publication-title: Cadernos de Saúde Pública
  doi: 10.1590/S0102-311X2010000500012
– volume: 18
  start-page: 119
  year: 2019
  ident: 2023071115181474900_R24
  article-title: Introducing new vaccines in low- and middle-income countries: challenges and approaches
  publication-title: Expert Review of Vaccines
  doi: 10.1080/14760584.2019.1574224
– volume: 15
  start-page: 1277
  year: 2005
  ident: 2023071115181474900_R29
  article-title: Three approaches to qualitative content analysis
  publication-title: Qualitative Health Research
  doi: 10.1177/1049732305276687
– volume: 9
  start-page: 439
  year: 2020
  ident: 2023071115181474900_R51
  article-title: Comparing 3 approaches for making vaccine adoption decisions in Thailand
  publication-title: International Journal of Health Policy and Management
– volume: 16
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R48
  article-title: Decision-making process for introduction of maternal vaccines in Kenya, 2017–2018
  publication-title: Implementation Science
  doi: 10.1186/s13012-021-01101-7
– volume: 34
  start-page: 271
  year: 2019
  ident: 2023071115181474900_R5
  article-title: Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czz027
– volume: 31
  start-page: C114
  year: 2013
  ident: 2023071115181474900_R15
  article-title: Systematic documentation of new vaccine introduction in selected countries of the Latin American Region
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2013.05.032
– volume: 11
  start-page: 1
  year: 2018
  ident: 2023071115181474900_R47
  article-title: Quantitizing and qualitizing (im-)possibilities in mixed methods research
  publication-title: Methodological Innovations
  doi: 10.1177/2059799118789021
– volume: 18
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R68
  article-title: Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
  publication-title: Human Vaccines and Immunotherapeutics
  doi: 10.1080/21645515.2021.1893062
– year: 2020
  ident: 2023071115181474900_R21
  article-title: Annual progress report 2020
– volume: 21
  start-page: 1
  year: 2021
  ident: 2023071115181474900_R34
  article-title: COVID19 vaccine intentions in South Africa: health communication strategy to address vaccine hesitancy
  publication-title: BMC Public Health
  doi: 10.1186/s12889-021-12196-4
– volume: 65
  start-page: 1751
  year: 2007
  ident: 2023071115181474900_R41
  article-title: What influences government adoption of vaccines in developing countries? A policy process analysis
  publication-title: Social Science & Medicine
  doi: 10.1016/j.socscimed.2007.05.054
– volume: 144
  year: 2021
  ident: 2023071115181474900_R59
  article-title: National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects
  publication-title: Preventive Medicine
  doi: 10.1016/j.ypmed.2020.106335
– year: 2021
  ident: 2023071115181474900_R65
  article-title: WHO recommends groundbreaking malaria vaccine for children at risk
– volume: 37
  start-page: 3646
  year: 2019
  ident: 2023071115181474900_R4
  article-title: Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health’s Partnership for influenza vaccine introduction
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2019.05.046
– volume: 31
  start-page: 1079
  year: 2016
  ident: 2023071115181474900_R25
  article-title: Introduction of pentavalent vaccine in Indonesia: a policy analysis
  publication-title: Health Policy and Planning
  doi: 10.1093/heapol/czw038
– volume: 33
  start-page: 28
  year: 2015
  ident: 2023071115181474900_R31
  article-title: Evidence-based decision-making for vaccine introductions: overview of the ProVac International Working Group’s experience HHS public access
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.10.090
– volume: 10
  start-page: 1
  year: 2022
  ident: 2023071115181474900_R1
  article-title: Human papillomavirus vaccination in South Africa: programmatic challenges and opportunities for integration with other adolescent health services?
  publication-title: Frontiers in Public Health
  doi: 10.3389/fpubh.2022.799984
– volume: 37
  start-page: 464
  year: 2019
  ident: 2023071115181474900_R13
  article-title: Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National Immunization Technical Advisory Group (NITAG)
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.11.062
– volume: 22
  start-page: 233
  year: 2004
  ident: 2023071115181474900_R12
  article-title: Translational research to assist policy decisions about introducing new vaccines in developing countries
  publication-title: Journal of Health, Population, and Nutrition
– volume: 33
  start-page: A34
  year: 2015
  ident: 2023071115181474900_R6
  article-title: Strengthening national decision-making on immunization by building capacity for economic evaluation: implementing ProVac in Europe
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.12.073
– year: 2022
  ident: 2023071115181474900_R32
  article-title: The U.S. Government & Gavi, the vaccine alliance | KFF
– volume: 15
  year: 2015
  ident: 2023071115181474900_R63
  article-title: Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
  publication-title: BMC Public Health
  doi: 10.1186/s12889-015-1638-0
– volume: 26
  start-page: 398
  year: 2009
  ident: 2023071115181474900_R11
  article-title: Descriptive analysis of immunization policy decision making in the Americas
  publication-title: Revista Panamericana de Salud Publica = Pan American Journal of Public Health
  doi: 10.1590/S1020-49892009001100003
– volume: 169
  start-page: 467
  year: 2018
  ident: 2023071115181474900_R57
  article-title: PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
  publication-title: Annals of Internal Medicine
  doi: 10.7326/M18-0850
– volume: 28
  start-page: A104
  year: 2010
  ident: 2023071115181474900_R40
  article-title: Immunization policy development in Thailand: the role of the advisory committee on immunization practice
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.02.043
SSID ssj0014445
Score 2.4561777
SecondaryResourceType review_article
Snippet Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous...
Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 363
SubjectTerms Affordability
Clinical decision making
Criteria
Data
Data points
Decision making
Delivery of Health Care
Developing Countries
Disease
Economic factors
Extraction
Financing
Health care
Health initiatives
Humans
Immunization
Low income groups
Medical screening
Policy making
Search methods
Search strategies
Sociocultural factors
Subject headings
Systematic review
Vaccination
Vaccines
Title Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review
URI https://www.ncbi.nlm.nih.gov/pubmed/36315461
https://www.proquest.com/docview/3051258704
https://www.proquest.com/docview/2730643506
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEA6yT4KIt-tFFMGnYNscu_VNxMUD9GWFfStpmsDibrvs4fXrnWm6hfVAn5ukpZOZ-ZKZ-YaQU8CoXFoXMhOnLQbnL9S5TDINQC6yIThwnyD7oG6exF1P9iqy6MkPIfyYn4NRGhWDc_OhTRCjtQUPjCz53cdeHS8QQsiakvHrlAWXs1DG9g1Nll6ls0ZWKzhIL7381smSzTfIir9Lo75EaJO8dXxTHNqvOoqAu6EA3Oho3C-QlMiXUtLC0RdtMFI-oek7HZWUv0P9bMupdFC8MqrzjA7LSwmGvAxDS8tuEXhgvqCaYpEKru4rWrZIt3PdvbphVccEZgQPpiyNsthJG6UZwBwbtWzssrDlnIrSoC0c7BoJPtpkqo3MjLLlOI-FNZbrOI1MzLdJIy9yu0uoDLULVWAUV0ZYzdsmyySCA0xH5aluEjb_p4mp2MSxqcUg8VFtnngZJJUMmuSsHj_yPBq_jjwBEf056GAuwaRSukkCpgvgGhgg0STH9WNQF4yB6NwWs0kCaA1BmAxUk-x4ydev4ooDoFTh3n--YJ8sY-d5TEcL1QFpTMczewj4ZJoeATK_vT8qN-gnAtfpUA
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+the+prioritization+of+vaccines+by+policymakers+in+low-+and+middle-income+countries%3A+a+scoping+review&rft.jtitle=Health+policy+and+planning&rft.au=Guillaume%2C+Dominique&rft.au=Meyer%2C+Diane&rft.au=Dur-e-Nayab+Waheed&rft.au=Schlieff%2C+Meike&rft.date=2023-03-16&rft.pub=Oxford+Publishing+Limited+%28England%29&rft.issn=0268-1080&rft.eissn=1460-2237&rft.volume=38&rft.issue=3&rft.spage=363&rft.epage=376&rft_id=info:doi/10.1093%2Fheapol%2Fczac092&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2237&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2237&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2237&client=summon